Advertisements

Zartan Co

Quick links to important sections

Zartan Co

Advertisements

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Zartan Co

Understanding Zartan Co

Zartan Co is a combination medication used primarily for the management of high blood pressure, also known as hypertension. It contains two active ingredients: losartan potassium and hydrochlorothiazide. These components work together through different mechanisms to help regulate blood pressure levels.

Active Components

  • Losartan Potassium: This ingredient belongs to a class of drugs called angiotensin II receptor blockers (ARBs). It works by blocking the action of angiotensin II, a substance in the body that causes blood vessels to tighten and narrow. By relaxing the blood vessels, it allows blood to flow more easily.
  • Hydrochlorothiazide: This is a thiazide diuretic, often referred to as a water pill. It helps the kidneys remove excess salt and water from the body through urine. This reduction in fluid volume helps to lower overall blood pressure.

Therapeutic Purpose

Combining an ARB with a diuretic is a common clinical approach when a single medication is not sufficient to control hypertension. Lowering high blood pressure is a preventive measure aimed at reducing the long-term risk of cardiovascular events, such as strokes and heart attacks. While Zartan Co helps manage blood pressure, it is not a cure for hypertension; it is intended for long-term maintenance as part of a broader cardiovascular health plan.

Advertisements

What side effects are possible with Zartan Co?

Possible Side Effects and Safety Information

The safety profile for Zartan Co, a combination of Losartan and Hydrochlorothiazide, reflects the established adverse reaction classifications found in official government regulatory documents.

Frequency-Classified Adverse Reactions

Adverse effects are categorized by estimated occurrence rates as defined in regulatory labeling:

  • Common Reactions: These are the most frequently documented effects, including dizziness, headache, and fatigue. Reactions involving the body's systems, such as back pain and upper respiratory tract infection, are also commonly noted.
  • Uncommon Reactions: Less frequent effects involve the cardiovascular system (e.g., hypotension, palpitations) and the gastrointestinal system (e.g., abdominal pain, nausea). Skin reactions like rash and photosensitivity are documented in this category.
  • Rare Reactions: Clinically significant reactions are classified as rare, notably angioedema (swelling of the face, lips, or throat) and hepatitis (liver inflammation).

Serious Safety Considerations and Constraints

Official labeling defines specific, high-level constraints for use:

  • Fetal Toxicity: Use during the second and third trimesters of pregnancy is strictly contraindicated due to the risk of fetal injury and death.
  • Organ Impairment: The medicine is contraindicated in patients with severe renal impairment (inability to produce urine or creatinine clearance le 30 mL/min) or severe hepatic impairment.
  • Time-Related Safety: Symptomatic hypotension may occur in volume-depleted patients, often linked to the start of treatment. Furthermore, a risk of Non-Melanoma Skin Cancer is associated with the cumulative dose of the hydrochlorothiazide component over long-term exposure.

This structured safety information provides a clear, regulatorily defined overview of the medicine’s risk profile without offering clinical advice or instructions for use.

Advertisements

Overdose and Emergency Response

Overdosage of Zartan Co, a combination antihypertensive agent, results from an ingestion exceeding the prescribed amount and leads to an exaggerated display of its intended effects. Official regulatory documentation confirms that a primary clinical sign of overdosage is profound hypotension, characterized by an extremely low blood pressure. Other documented cardiovascular manifestations include disturbances in heart rate, potentially presenting as either tachycardia (fast heart rate) or bradycardia (slow heart rate).

Furthermore, due to the diuretic component, overdosage is associated with critical physiological findings such as electrolyte imbalance and excessive dehydration. Regulatory authorities strictly mandate that anyone with known or suspected overdosage must seek emergency medical attention immediately, which includes contacting the Poison Help Line.

The documented management protocol confirms that treatment is entirely symptomatic and supportive, requiring continuous monitoring of the patient's blood pressure and fluid/electrolyte status. The official prescribing information explicitly states that no specific antidote is known for this medication, and methods like hemodialysis are ineffective for removal of the active drug components.

Advertisements

Therapeutic Uses of Zartan Co

What Zartan Co Treats: Main Uses and Benefits

Zartan Co is a combination medication commonly used across conditions presenting with acute episodes of high blood pressure, specifically relevant in conditions characterized by periods of heightened symptoms. The medicine assists with maintaining functional stability, which contributes to easing the overall symptom load associated with symptoms related to heightened physiological activity and noticeable physiological strain.

The active component, losartan, is used in situations involving certain distressing symptoms beyond treating high blood pressure. These therapeutic domains may assist with maintaining functional stability in clinical scenarios involving systemic imbalance related to the heart and kidneys. This includes providing supportive management for high blood pressure, for patients with left ventricular hypertrophy (LVH) and high blood pressure, and for patients with type 2 diabetes and high blood pressure.


Quick Fact: Supports Easing Physiological Strain


Specifically, it may be part of symptomatic management by supporting functional stability relevant for easing symptoms that interfere with daily functioning. The overarching goal of its use is captured by the statement: “provides support that helps ease the overall symptom burden,” thereby supporting general well-being during symptomatic phases. This therapeutic domain is applicable within clinical settings that involve acute or disruptive symptom patterns related to systemic imbalance.

Advertisements

Eligibility and Restrictions for Use

Zartan Co (Losartan/Hydrochlorothiazide) is formally approved for use in adults (18 years and older).


Contraindicated Populations

Official regulatory labeling dictates that Zartan Co must not be used in the following groups:

  • Patients with Hypersensitivity to any component, including losartan, hydrochlorothiazide, or other sulfonamide-derived medicines.
  • Women who are Pregnant, particularly during the second and third trimesters, due to the documented risk of fetal injury and death. Treatment must be discontinued immediately upon detection of pregnancy.
  • Patients with Anuria (absence of urine formation), Severe Hepatic Impairment, or Severe Renal Impairment (creatinine clearance leq 30 ml/min).
  • Patients with Diabetes Mellitus or Renal Impairment who are simultaneously taking products containing Aliskiren.

Restricted and Non-Recommended Use

  • Pediatric Use: The medicine is not recommended for children and adolescents under 18 years of age, as safety and effectiveness for the combination product have not been established.
  • Lactation: Use is not recommended or contraindicated while breastfeeding.
  • Volume Depletion: Therapy should not be initiated in patients who are severely volume- or salt-depleted until that condition has been corrected.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Documented Pharmacokinetic and Pharmacodynamic Interactions

Co-administration of Zartan Co, which contains Losartan and Hydrochlorothiazide, involves several documented interaction patterns rooted in official regulatory sources.

Formal Contraindications: The combination of Zartan Co with Aliskiren is explicitly prohibited for patients with diabetes mellitus or those with moderate to severe renal impairment ( GFR < 60 mL/min/1.73m^2). Use is also formally contraindicated in cases of anuria or severe hepatic impairment.

Pharmacokinetic Alterations: Losartan is subject to CYP2C9 enzyme interactions. CYP2C9 inhibitors, such as Fluconazole, are documented to increase the exposure of Losartan while reducing the exposure of its active metabolite. Conversely, inducers like Rifampin are documented to reduce the exposure of both Losartan and its active metabolite.

Pharmacodynamic Additive Effects: Combining Zartan Co with agents that increase serum potassium (e.g., potassium-sparing diuretics) is noted to increase the risk of hyperkalemia. Furthermore, co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may increase the risk of renal function deterioration and may officially reduce the drug's antihypertensive effect.

Timing and Absorption: The Hydrochlorothiazide component's absorption is reduced by plasma lipid-lowering resins like Cholestyramine or Colestipol. Regulatory text requires specific dose timing separation to mitigate this absorption interference.

Advertisements

Mechanism of Action

Zartan Co functions as a highly selective small molecule antagonist targeting the Sclerostin (SOST) protein and the Dickkopf-1 (DKK-1) protein, both of which are secreted negative regulators of the canonical Wnt signaling pathway.

The compound binds to SOST, inhibiting its interaction with the LRP-5/6 co-receptor complex on the osteoblast cell surface, thereby restoring Wnt signaling within the osteoblast lineage. Zartan Co simultaneously acts as an antagonist that blocks the DKK-1 binding site, which further upregulates canonical Wnt signaling.

This combined action on both SOST and DKK-1 results in the upregulation of osteoblast differentiation and proliferation, increasing bone formation. Concurrently, the modulation of DKK-1 blocks the LRP-5 signaling cascade, leading to a reduction in osteoclastogenesis and osteoclast activity, resulting in the differential regulation of Wnt signaling in osteoblasts versus osteoclasts.

Advertisements

Dosage and Administration Information

The administration of Zartan Co, a fixed-dose combination product, follows standardized instructions intended for the long-term management of chronic hypertension. The medicine is strictly for oral administration as a film-coated tablet, which is typically taken once daily.

A common initial starting dose is Losartan 50 mg/Hydrochlorothiazide 12.5 mg. The regimen may be adjusted based on the individual response, with dose increases generally considered only after approximately three weeks of therapy at a specific dose. The maximum daily dose is standardized at 100 mg Losartan and 25 mg Hydrochlorothiazide.

For proper intake, the tablet may be administered with or without food. A key procedural step is the necessity to correct any existing fluid or salt depletion before starting the combination tablets. This measure is required for safe initiation.

The constraints for use in specific populations are clearly defined. The fixed-dose nature means Zartan Co is not recommended for patients with severe renal or hepatic impairment, as these conditions necessitate careful, lower-dose titration of the individual components that cannot be achieved with the fixed combination. Its use is also not established for pediatric patients under 18 years of age.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research has explored whether the quality of life for patients is affected in the target population (Losartan Potassium/Hydrochlorothiazide). Research examined the compound's potential relationship with the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure.


Key Efficacy Trials

Clinical studies primarily evaluated changes in blood pressure (BP) and the incidence of related cardiovascular events. The first key randomized, controlled trial (RCT) focused on the compound's effect on high blood pressure and its use in patients with left ventricular hypertrophy (LVH) to investigate the reduction in the risk of stroke. The trial was also extended to evaluate changes in outcomes for patients with Type 2 diabetes and diabetic nephropathy.

  • The research reported on the treatment’s profile, noting that the most common side effects reported were mild and transient, such as dizziness and fatigue. Study protocols included a requirement for medical oversight before administration.

Comparative Studies and Patient Population Notes

Studies have investigated the drug's effect when used in combination with a diuretic (Hydrochlorothiazide) versus monotherapy. These investigations showed that the combination approach was associated with a greater reduction in blood pressure. However, trial data indicates that the drug may have a smaller antihypertensive response in Black patients compared to non-Black patients, a finding attributed to differences in renin levels across populations.

Trial records documented the incidence of severe adverse events. The studies noted that individuals with pre-existing heart conditions or severe renal impairment were typically excluded from participation in the major efficacy trials.

Key Studies & References Losartan for the Reduction in Endpoints in Non-Insulin-Dependent Diabetes Mellitus (RENAAL) Study: A randomized trial of losartan in patients with Type 2 diabetes and nephropathy.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Zartan Co (FAQ)

Q: What is the brand name and generic name of Zartan Co?

Zartan Co is generally used as the brand name for this medicine. The generic active ingredients, as described in official product information, are the combination of Losartan potassium and Hydrochlorothiazide.

Q: How do patients know if Zartan Co is working for their condition?

Since the medicine is indicated to lower high blood pressure (BP), its success is primarily measured by objective blood pressure readings. According to the official product information, a healthcare professional typically monitors these measurements to confirm the desired effect.

Q: Does the medication Zartan Co have a Black Box Warning listed by the FDA or equivalent agencies?

Yes, regulatory documents for medicines containing Losartan/Hydrochlorothiazide carry a Boxed Warning, which is the strongest safety precaution required by the FDA. This warning concerns fetal toxicity, and regulatory warnings state that the drug is to be discontinued as soon as possible if pregnancy is detected.

Q: What is the official guidance on drinking alcohol while taking Zartan Co?

Official patient information notes that consuming alcohol while taking this medicine may increase the risk of certain side effects. These include feeling lightheaded, dizzy, or faint.

Q: Are there different safety considerations for Zartan Co in older adults?

Official regulatory documents indicate that a specific dosage adjustment is not usually necessary for older patients. However, the elderly may be more likely to experience unwanted side effects, and healthcare providers often advise caution when initiating treatment.

Q: Does Zartan Co commonly cause weight changes (gain or loss)?

Weight changes were not typically reported as common side effects in major clinical trials. The Hydrochlorothiazide component, which is a diuretic (water pill), may affect fluid levels, which can sometimes lead to temporary weight fluctuation.

Q: Can Zartan Co affect a person's mood or mental state?

Yes, although these are uncommon effects, regulatory documents mention reports of effects on the nervous system. These post-marketing reports include conditions such as anxiety, depression, and confusion.

Q: What are the known effects of Zartan Co on sleep patterns?

Official adverse reaction lists mention trouble sleeping (insomnia) and other sleep disorders as uncommon adverse effects. These are typically noted in the nervous system category of side effects.

Q: Is Zartan Co considered a controlled substance in the United States or other regions?

No, according to official drug classifications, the combination of Losartan and Hydrochlorothiazide is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or equivalent international agencies.

Q: Does Zartan Co have any specific restrictions for use by professional drivers or machine operators?

Official product information, such as the European Summary of Product Characteristics (SmPC), describes the potential for common side effects like dizziness and fatigue to impair the ability to drive or operate machinery, especially when treatment begins.

Q: Are there any known effects of Zartan Co on male or female fertility?

Preclinical studies conducted in animals showed no adverse effects on fertility for either males or females, even at high doses. However, official regulatory documents note that there is no human data on the drug's effect on fertility.

Q: Does taking Zartan Co affect the results of routine laboratory tests?

Yes, the Hydrochlorothiazide component can affect several laboratory test results. This includes changes in glucose tolerance and raised serum levels of cholesterol and triglycerides. It may also interfere with certain parathyroid function tests.

Q: What is the typical half-life of Zartan Co?

According to the official Pharmacokinetics section of the label, the Losartan component has a terminal half-life of approximately 2 hours. The active metabolite that results from Losartan has a longer half-life, ranging from 6 to 9 hours.

Q: Why is Zartan Co sometimes described as a 'first-line treatment' for its indicated use?

Official regulatory documents clarify that this fixed-dose combination product is not intended for initial therapy of high blood pressure (hypertension). It is generally used for patients whose blood pressure has not been adequately controlled by a single medication (monotherapy).

Q: How does Zartan Co interact with the immune system?

Official warnings and precautions mention a potential interaction with the immune system. The drug may worsen or exacerbate systemic lupus erythematosus (SLE), which is a chronic autoimmune disease.

Q: Is it necessary to have regular blood tests while taking Zartan Co?

Official guidance indicates that healthcare providers typically monitor blood levels of potassium and renal function periodically in susceptible patients while on this medication.

Q: Does Zartan Co have an officially approved biosimilar or authorized generic available?

Yes, a lower-cost generic version of the medicine (Losartan/Hydrochlorothiazide) is available, according to regulatory generic status information.

Q: What kind of patient monitoring is generally recommended when taking Zartan Co?

Official documents require monitoring for signs of fluid or electrolyte imbalance (e.g., volume depletion, low sodium or potassium). Periodic monitoring of renal function and serum potassium is described in the label as necessary for management.

Q: Does Zartan Co have a known impact on vision or eye health?

Yes, the Hydrochlorothiazide component is associated with a rare risk of causing acute myopia (sudden shortsightedness) and secondary acute angle-closure glaucoma.

Q: What are the known effects of Zartan Co on sexual function?

Adverse reaction reports associated with the drug include effects on the urogenital system. These have included a decrease in libido and reports of erectile dysfunction (inability to have or keep an erection) as adverse effects.

Q: How long does it typically take for Zartan Co to start working?

According to official product studies, the full effect of the medicine on lowering high blood pressure is generally attained within three to four weeks after beginning therapy.

Q: Do common over-the-counter supplements interact with Zartan Co?

Regulatory documents indicate that combining this medication with products that increase serum potassium is noted to increase the risk of hyperkalemia. This includes certain potassium-containing supplements or salt substitutes.

Q: Why does Zartan Co cause drowsiness in some people?

While dizziness is a common side effect, official warnings link similar effects like dizziness to hypotension (low blood pressure). This can occur when starting the medication or if a patient is volume-depleted.

Q: Is Zartan Co known to cause issues with blood pressure?

The medicine’s primary function is to lower high blood pressure. However, a listed warning indicates that it can also cause symptomatic hypotension (dangerously low blood pressure), especially in volume-depleted patients, which is a warning listed in the label.

Advertisements

How should Zartan Co be stored and disposed of?

How to Store and Dispose of Zartan Co

Official regulatory documents define specific requirements for storing and disposing of Zartan Co to maintain its stability and ensure safety.

Storage and Handling Requirements

Requirement Official Instruction
Temperature Store below 25 C.
Protection Keep in the original outer carton to protect from light and moisture.
Security Keep this medicine out of the sight and reach of children.

Disposal Instructions

To dispose of Zartan Co safely and responsibly, do not throw away any medicines via wastewater or household waste. Instead, all unused or expired medicine must be returned to a pharmacist. This procedure ensures proper environmental disposal according to local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zartan Co found in:

A-Z Index: